These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36333207)

  • 1. Cost-effectiveness of bivalirudin in pediatric ventricular assist devices.
    Burstein D; Kimmel S; Putt M; Rossano J; VanderPluym C; Ankola A; Lorts A; Maeda K; O'Connor M; Edelson J; Lin K; Buchholz H; Conway J
    J Heart Lung Transplant; 2023 Mar; 42(3):390-397. PubMed ID: 36333207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
    Campbell CT; Diaz L; Kelly B
    Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices.
    Pieri M; Agracheva N; Di Prima AL; Nisi T; De Bonis M; Isella F; Zangrillo A; Pappalardo F
    Artif Organs; 2014 Apr; 38(4):342-6. PubMed ID: 24102357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy.
    Rutledge JM; Chakravarti S; Massicotte MP; Buchholz H; Ross DB; Joashi U
    J Heart Lung Transplant; 2013 May; 32(5):569-73. PubMed ID: 23465252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin Experience in a Heterogeneous Ventricular Assist Device Population.
    Bates A; Buchholz H; Freed D; MacArthur R; PiDBorochynski T; Conway J
    ASAIO J; 2020 Jun; 66(6):677-682. PubMed ID: 31567418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
    Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
    Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database.
    Pinto DS; Kohli P; Fan W; Kirtane AJ; Kociol RD; Meduri C; Deliargyris EN; Prats J; Reynolds MR; Stone GW; Michael Gibson C
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):363-73. PubMed ID: 26011467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes.
    Schwenkglenks M; Brazier JE; Szucs TD; Fox KA
    Value Health; 2011 Jan; 14(1):24-33. PubMed ID: 21211483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin Compared to Heparin as the Primary Anticoagulant in Pediatric Berlin Heart Recipients.
    Freniere V; Salerno DM; Corbo H; Law S; McAllister J; Neunert C; Chen JK
    ASAIO J; 2023 May; 69(5):e205-e211. PubMed ID: 36943709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs associated with ventricular assist device use in children.
    Mahle WT; Ianucci G; Vincent RN; Kanter KR
    Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time in Therapeutic Range for Bivalirudin Among Pediatric Ventricular Assist Device Recipients.
    Daugherty J; Heyrend C; Profsky M; Kay B; VanderPluym C; Griffiths ER; May LJ
    ASAIO J; 2021 May; 67(5):588-593. PubMed ID: 32826396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction.
    Schwenkglenks M; Toward TJ; Plent S; Szucs TD; Blackman DJ; Baumbach A
    Heart; 2012 Apr; 98(7):544-51. PubMed ID: 22313548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding.
    Amin AP; Marso SP; Rao SV; Messenger J; Chan PS; House J; Kennedy K; Robertus K; Cohen DJ; Mahoney EM
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):358-65. PubMed ID: 20488917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisal.
    Simpson EL; Fitzgerald P; Evans P; Tappenden P; Kalita N; Reckless JP; Bakhai A
    Pharmacoeconomics; 2013 Apr; 31(4):269-75. PubMed ID: 23512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support.
    VanderPluym CJ; Cantor RS; Machado D; Boyle G; May L; Griffiths E; Niebler RA; Lorts A; Rossano J; Sutcliffe DL; Lytrivi ID; Buchholz H; Fynn-Thompson F; Hawkins B; Conway J
    ASAIO J; 2020 Aug; 66(8):939-945. PubMed ID: 32740356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information System.
    Rossano JW; Cantor RS; Dai D; Shamszad P; Huang YS; Hall M; Lin KY; Edens RE; Parrino PE; Kirklin JK
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018-2022.
    Engel ER; Perry T; Block M; Palumbo JS; Lorts A; Luchtman-Jones L
    Pediatr Crit Care Med; 2024 Jul; 25(7):e328-e337. PubMed ID: 38713010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results.
    Mishkel GJ; Moore AL; Markwell SJ; Ligon RW
    J Invasive Cardiol; 2007 Feb; 19(2):63-8. PubMed ID: 17268039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource utilization in children with paracorporeal continuous-flow ventricular assist devices.
    Burstein DS; Griffis H; Zhang X; Cantor RS; Dai D; Shamszad P; Huang YS; Morales DLS; Hall M; Lin KY; O'Connor MJ; Zinn M; Edens RE; Parrino PE; Kirklin JK; Rossano JW
    J Heart Lung Transplant; 2021 Jun; 40(6):478-487. PubMed ID: 33744087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
    Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.